BSX Financial Statements & Analysis
Complete financial statements for BSX including income statement, balance sheet, and cash flow statement. Analyze BSX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
52
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
17.6% ↑
Net Income
16.4% ↑
Gross Margin
-1.1% ↓
Operating Margin
2.7% ↑
Balance Sheet
Current Ratio
-18.1% ↓
Debt to Equity
4.0% ↓
Asset Turnover
4.9% ↑
Cash Flow
Operating Cash Flow
37.2% ↑
Net Cash Flow
-447.6% ↓
Free Cash Flow
55.3% ↑
Cash Flow to Debt
16.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 14.24B | 16.75B | 17.6% | |
| Gross Profit | 8.83B | 10.27B | 16.3% | |
| Operating Income | 2.18B | 2.63B | 20.8% | |
| Net Income | 1.59B | 1.85B | 16.4% | |
| EPS | 1.0805 | 1.2593 | 16.5% | |
| EBITDA | 3.45B | 3.94B | 14.0% | |
| Gross Margin | 62.02% | 61.31% | 1.1% | |
| Operating Margin | 15.32% | 15.73% | 2.7% | |
| Net Income Margin | 11.19% | 11.07% | 1.0% | |
| R&D Expenses | 1.41B | 1.61B | 14.2% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 16.75B | 14.24B | 12.68B | 11.89B | 9.91B |
| Gross Profit | 10.27B | 8.83B | 7.71B | 7.46B | 5.58B |
| Operating Income | 2.63B | 2.18B | 1.82B | 1.92B | 601.00M |
| Net Income | 1.85B | 1.59B | 698.00M | 1.04B | -82000000 |
| EPS | 1.2593 | 1.0805 | 0.4488 | 0.6925 | -0.0812 |
| EBITDA | 3.94B | 3.45B | 2.74B | 2.52B | 1.51B |
| Gross Margin | 61.31% | 62.02% | 60.83% | 62.76% | 56.25% |
| Operating Margin | 15.73% | 15.32% | 14.38% | 16.17% | 6.06% |
| Net Income Margin | 11.07% | 11.19% | 5.50% | 8.75% | -0.83% |
| R&D Expenses | 1.61B | 1.41B | 1.32B | 1.20B | 1.14B |